1 / 81

Board Review 2009

Board Review 2009. Hypo/Hyper natremia mixed acid/base disturbances Nephrotic Syndrome Glomerulonephitis RTAs Calcium/Phosphate homeostasis renal vasculitis pictures of urine sediment ATN AIN CKD staging and principles of management Indications for renal transplant

kira
Télécharger la présentation

Board Review 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Board Review 2009 • Hypo/Hyper natremia • mixed acid/base disturbances • Nephrotic Syndrome • Glomerulonephitis • RTAs • Calcium/Phosphate homeostasis • renal vasculitis • pictures of urine sediment • ATN • AIN • CKD staging and principles of management • Indications for renal transplant • Below is a list of topics that our residents did not do well on during the In-Training exam: • diagnosis of primary hyperaldosteronism in metabolic alkalosis • diagnose type 4 rta • diagnose psychogenic polydipsia • diagnose mixed acid/base disturbances • diagnose membranous GN • evaluate PCKD • diagnose IgA nephropathy • manage proteinuria in CKD

  2. Question 1 A 65 y.o. male is referred for evaluation of edema and proteinuria. He complains of fatigue, but otherwise is asymptomatic. On exam the BP is 150/80. There is 1+ ankle edema. Labs show hemoglobin 10 (MCV 74, RDW 20); urine protein:creatinine ratio is 4.4 mg/gm, serum creatinine is 1 mg/dL, and cholesterol is 320 mg/dL. Serum complement levels are normal. Urinalysis shows 3+ protein, hyalofatty casts and oval fat bodies. Which of the following is the most likely cause of this patient’s renal symptoms? • Minimal change glomerulopathy • FSGS • Membranous glomerulopathy • IgA nephropathy • ANCA-associated GN

  3. Question 2 A 19 y.o. female is evaluated for sudden onset periorbital and pretibial edema. 3 weeks ago she was diagnosed with an URI that has since resolved. On PE the BP is 150/100. A soft S3 gallop is present. There are crackles at both lung bases. The liver is enlarged and tender. There is bilateral pitting pretibial edema. There is no rash. Labs show creatinine 1.5, albumin 3.8. C3 and C4 are low. Urinalysis shows rare dysmorphic red cells and trace protein. Which of the following is the most likely diagnosis? • IgA nephropathy • Goodpasture's syndrome • ANCA vasculitis • Postinfectious GN • SLE nephritis

  4. Question 3 A 19 y.o. female presents with a several month history of symmetric arthralgias, Raynaud’s phenomenon, and a Coomb’s positive hemolytic anemia. On physical exam she has a malar rash that crosses the nasal labial folds. The heart and pulmonary exams are unremarkable. Her abdomen is benign. There is 1 + leg edema. Urinalysis shows red cell casts and 2+ protein. A kidney biopsy shows immune complex focal proliferative glomerulonephritis. Which if the following tests provides the most additional diagnostic information? • Low C 3 and C4 • Positive ANA • Positive ss-DNA • Positive anti-Smith antibody • Positive ds-DNA

  5. Question 4 A 51-year-old man with a history of chronic lymphocytic leukemia with transformation to prolymphocytic leukemia is hospitalized for chemotherapy with R-CHOP (cyclophosphamide doxorubicin vincristine prednisone rituximab). On physical examination, he is afebrile, pulse rate is 98/min, respiratory rate is 16/min, and blood pressure is 134/78 mm Hg. There is lymphadenopathy involving the cervical and submental chains and supraclavicular areas bilaterally, as well as bulky axillary and inguinal lymphadenopathy. Cardiac and pulmonary examinations are normal. The spleen is palpable approximately 3 cm to 4 cm below the left costal margin, and there is no hepatomegaly. There is no edema, cyanosis, or clubbing of the extremities. Labs show hematocrit 22%, leukocyte count 110,000/µL, platelet count 19,000/µL, BUN 63 mg/dL, uric acid 19 mg/dL, creatinine 1.3 mg/dL, potassium 5.5 meq/L, bicarbonate 17 meq/L, albumin 4.2 g/dL, calcium 7.5 mg/dL, phosphorus 5 mg/dL, urinalysis pH 5, numerous finely granular casts/hpf, no uric acid crystals In addition to hospitalization for intravenous hydration, which of the following is the most appropriate next step in this patient’s management? A. Furosemide B. Rasburicase C. Allopurinol D. Probenecid

  6. Tumor Lysis Syndrome • Acute oliguric renal failure associated with urate levels > 15 mg/dl and hyperphosphatemia • Associated with overproduction and excretion of urate and cell lysis resulting in increased release of potassium and phosphorus in patients undergoing chemotherapy or with a heavy tumor burden • Urine urate/creatinine > 1 • Prevention: allopurinol 600-900 mg/d + NS (uo > 2.5 l/d) • Urinary alkalinization may worsen calcium phosphate precipitation and NS is as effective as urinary alkalinization alone • Early dialysis indicated for oliguric ARF to decrease urate burden

  7. Risk Stratification for TLS *From Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008; 26:2767-78.

  8. Prevention of TLS • If there is a concern about tumor lysis, as predicted by an elevated serum LDH, serum uric acid, or heavy tumor burden, the patient should be admitted for hydration and close monitoring of kidney function, serum potassium, phosphorus and uric acid. • Patients with a preexisting reduction in GFR, oliguria and/or acidic urine, and volume depletion should also be hospitalized for hydration and observation. • High-risk patients should be hospitalized for aggressive intravenous hydration and prophylactic rasburicase. • Intermediate risk patients should receive allopurinol rather than rasburicase for prophylaxis in the absence of pretreatment hyperuricemia. • Patients at low risk for TLS should receive hydration, but do not require hypouricemic therapy.

  9. Question 5 A 64-year-old woman is evaluated for progressive weakness, nausea, dyspnea, and acute renal failure of several weeks’ duration. Her creatinine level is 4.6 mg/dL (last creatinine is 1.3 mg/dL 2 months ago). She has a history of type 2 diabetes mellitus and hypertension treated with metoprolol and hydrochlorothiazide. Other medications include aspirin and glipizide. On physical examination, the blood pressure is 110/70 mm Hg. Fundoscopic examination reveals arteriovenous nicking but no evidence of diabetic retinopathy. Cardiac examination shows a laterally displaced PMI and a grade I holosystolic murmur at the apex. On pulmonary examination, the lungs are clear to auscultation. There is no pedal edema. Hemoglobin 12.8 g/dL, leukocyte count 8000/µL, platelet count 311,000/µL, BUN 48 mg/dL, uric acid 11.6 mg/dL, creatinine 4.6 mg/dL, sodium 140 meq/L, potassium 4.3 meq/L, chloride 110 meq/L, bicarbonate 26 meq/L, total protein 8.4 g/dL, albumin 3.8 g/dL, calcium 10.5 mg/dL, phosphorus 5.6 mg/dL, lactate dehydrogenase 634 U/L; Urinalysis pH 6.5, trace protein, trace blood, 2 leukocytes/hpf, amorphous crystals. Urine sodium 60 meq/L, urine creatinine 90 mg/dL, urine protein–creatinine ratio 3 mg/mg Renal ultrasound shows enlarged hyperechoic kidneys bilaterally measuring 14 cm in length. Chest radiograph reveals mild cardiomegaly but is otherwise unremarkable. Which of the following is the most likely diagnosis? A. Uric acid nephropathy B. Thiazide-induced acute renal failure C. Primary amyloidosis D. Myeloma cast nephropathy E. Lymphomatous infiltration of the kidneys

  10. Question 6 A 38 y.o. man with a history of chronic liver disease secondary to hepatitis C is treated with a 24-wk course of pegalated IFN combined with ribavarin. Four weeks after completing treatment he complains of proximal muscle weakness. On PE the BP is 120/80, pulse 110, RR 18. His general exam is unremarkable. On neurologic exam he has symmetric proximal weakness 3/5. Labs show Na 142, K 2.1, Cl 104, HCO3 20, creat 1. Urine Na 100, urine K 10, urine Cl 110, urine osm 585, urine pH 5.3. Which of the following is the most likely diagnosis? • Distal renal tubular acidosis (type I) • Vomiting • Diuretic abuse • IFN complication • Hypomagnesemia • Diarrhea

  11. Question 7 A 34 year old woman who underwent elective laparoscopic cholecystectomy develops severe headache and nausea the next morning. During the surgery, D5½NS was started and continued postoperatively at 125 mL/hr. She remained in recovery until late afternoon because she was too sedated to be discharged. Intravenous meperidine is administered with adequate relief of her pain. On physical exam the blood pressure is 130/80. She is afebrile. The heart and lung exams are normal. There is no peripheral edema. Neurologic exam is remarkable only for lethargy. Laboratory studies show sodium 128, potassium 3.4, chloride 86, bicarbonate 28, BUN 10, creatinine 0.8, glucose 86. Urine sodium 46, urine osmolality 453. Which of the following should be done next? • NS 200 mL/hr + furosemide • 3% saline at 1 ml/kg/hr + furosemide • Emergent head CT • Naloxone • Observation

  12. Symptomatic Hyponatremia: Recommendations for Management • 3% saline at average rate of 1 mL/kg/hr over first 24 hours + furosemide if urine osm > 300 mOsm/kg or risk of CHF • Stop therapy when symptoms resolve • Measure the serum sodium every 1-2 hours for the first 6 hours and then every 4 hours • Do not exceed 10 mEq/L in 24 hours or 18 mEq/L in 48 hours in a symptomatic patient with chronic hyponatremia

  13. Hyponatremia: Recommendations for Management • Do not use fluid restriction alone in the symptomatic patient • If the serum sodium increases too rapidly, interrupt the increase by starting hypotonic fluids and/or dDAVP 4 micrograms s.c. • Do not use 0.9% NaCl for symptomatic patients with SIADH, especially when the urine osm is > 300 mOsm/kg • Do not use vaptan therapy for symptomatic patients

  14. Question 8 A 46 y.o. male is hospitalized for severe necrotizing pancreatitis. He is placed on NG suction and over the first 24 hours of hospitalization he receives 6 liters of NS and then NS at 100 mL/hour. Over the next 24 hours his urine output increases to > 3 liters per day and his plasma sodium concentration rises from 145 meq/L on admission to 153 meq/L. On exam the blood pressure is 140/90. Chest is clear . There is no edema. Labs show sodium 153, potassium 3, chloride 112, bicarbonate 24, BUN 49, creatinine 1.1, urine sodium 50, urine potassium 20, urine osmolality 500 mosm/kg. Which of the following is the most likely cause of this patient’s polyuria? • Central diabetes insipidus • Nephrogenic diabetes insipidus • Post obstructive diuresis • Solute diuresis

  15. Polyuria • Urine output exceeding 3 L per day • Etiology • Water diuresis • diabetes insipidus • central • nephrogenic • primary polydipsia • Solute diuresis

  16. Evaluation of Polyuria Urine Osmolality < 250 mosm/kg > 300 mosm/kg Water Diuresis Solute Diuresis

  17. Urine and Plasma Osmolality in Disorders of Water Balance Normal 1000 Water Deprivation dDAVP 800 Primary polydipsia Uosm(mosm/kg) 600 Central DI 400 Nephrogenic DI 200 280 285 290 295 300 Posm(mosm/kg)

  18. Question 9 A 58-year-old woman with a history of chronic alcohol abuse is admitted to the hospital for evaluation of abdominal pain and vomiting. A diagnosis of recurrent pancreatitis is made on the basis of the history of alcoholism, the presence of diffuse abdominal tenderness and decreased bowel sounds, and elevated serum amylase and lipase levels. Therapy is begun with intravenous fluids (0.9% saline and 5% dextrose in water at 75 mL/hr) and nasogastric drainage, which produces copious amounts of fluid. After five days of therapy, the patient's symptoms resolve and the following laboratory studies are obtained: BUN 21 mg/dL, serum creatinine 1.4 mg/dL, plasma glucose180 mg/dL, serum sodium 140 mEq/L, potassium 2.6 mEq/L, chloride 86 mEq/L, bicarbonate 38 mEq/L, urine pH 7.0, urine sodium 50 mEq/L, urine chloride 5 mEq/L Which of the following best explains the hypokalemia in this patient? (A) Renal potassium losses derived from decreased proximal tubule reabsorption (B) Potassium loss in the gastric aspirate (C) Intracellular redistribution of potassium is a major determinant of the hypokalemia (D) Increased aldosterone and distal nephron bicarbonate delivery causing renal potassium losses

  19. Metabolic Alkalosis BP Volume status BP Normal or Low  Effective circulating volume BP High  ECF Loss of HCl Loss of Volume (Na+/H20) Primary Hyperaldosteronism Loss of Gastric secretions (vomiting, NG suction) Diuretics Bartter syndrome Gitelman syndrome

  20. Metabolic Alkalosis: Loss of Gastric Secretions-Generation Phase Loss of HCl from Stomach Generation of NaHCO3 Kidney 1. Elimination of chloride from the urine 2. Excretion of NaHCO3 and KHCO3 in Urine

  21. Metabolic Alkalosis: Loss of Gastric Secretions-Maintenance Phase Volume Contraction Reabsorption of sodium, chloride, and bicarbonate along the nephron Secondary increase in aldosterone Metabolic alkalosis Paradoxical aciduria Elimination of sodium, chloride, and bicarbonate from the urine Increased H+ Excretion

  22. Question 10 A 42 y.o. female is evaluated for minimal edema and a urinary protein excretion of 5 gm/24 hours. As a child she had frequent urinary tract infections and underwent a surgical procedure to reimplant the ureters to prevent reflux. On PE the BP is 140/95. There is trace peripheral edema. Labs show creatinine 1.5, albumin 3.4, Urinalysis shows 3 + protein and oval fat bodies. Chest x-ray is normal. Renal US shows a normal left kidney and the right kidney small and difficult to visualize. Which of the following is the most likely cause of the proteinuria? • Minimal change disease • Membranous nephropathy • FSGS • Membranoproliferative GN

  23. Focal Segmental Glomerulosclerosis (FSGS) • Most common cause for nephrotic syndrome in African-Americans • Occurs as a primary (idiopathic) glomerular disease and also secondary to recognized causes (such as obesity, HIV infection, and inherited genetic defects) • This is a pathologically and clinically heterogeneous category of disease that includes multiple structural variants with different demographics, clinical presentations and outcomes

  24. Perihilar Tip Lesion Collapsing Cellular Different Structural Variants of FSGS

  25. PRIMARY (IDIOPATHIC) FSGS SECONDARY FSGS VIRUS-ASSOCIATED HIV-1 (“HIV-associated nephropathy”) Parvovirus B-19 FAMILIAL FSGS Mutations in α-actinin 4 gene Mutations in NPHS2 gene for podocin Mutations in TRPC6 gene for a cation channel DRUG TOXICITY Heroin (“Heroin nephropathy”) Pamidronate Interferon-α MEDIATED BY ADAPTIVE STRUCTURAL RESPONSES Reduced renal mass Obesity Cyanotic congenital heart disease Sickle cell anemia

  26. Question 11 A 44 y.o. female with cirrhosis is admitted with fever and abdominal pain. Medications include spironolactone, furosemide, and lactulose. On exam the BP is 74/55, HR 72, T 38.3, RR 24. She is cachectic. The abdomen is tense and diffusely tender. There is 1+ leg edema. Labs show Serum sodium 128, potassium 5.1, chloride 104, bicarbonate 12, BUN 20, creatinine 1.3, glucose 84, albumin 1.4. ABG pH 7.25, pCO2 28, pO2 78. Which best describes the acid-base status of this patient? • Mixed anion gap metabolic acidosis and respiratory alkalosis • Mixed anion gap metabolic acidosis and respiratory acidosis • Anion gap metabolic acidosis • Hyperchloremic acidosis • Mixed anion gap metabolic acidosis and hyperchloremic acidosis

  27. Question 11 Analysis 1. What is the overriding disorder? Metabolic acidosis 2. What is the anion gap? 128-104-12 = 12, increased AG met acidosis (Normal anion gap is ~5.5 in this case due to the hypoalbuminemia- For every 1 gm/dL fall in the albumin from 4 gm/dL, the anion gap expected anion gap decreases 2.5 mEq/L). 3. What is the expected bicarbonate with pure AG metabolic acidosis? 25-(12-5.5) = 18.5 Meas bicarb is 12,  concurrent hyperchloremic metabolic acidosis 4. What is the expected pCO2 with normal respiratory compensation? Expect PCO2 = 12 + 15 = 27. Meas PCO2 is 28, normal resp comp Answer = Mixed AG met acid, hyperchloremic met acidosis

  28. Question 12 23-year-old Caucasian female referred for further evaluation of hypokalemic acidosis. She was in her usual state of excellent health with normal growth and development until her second month of pregnancy. She had a spontaneous miscarriage, and was found to have a serum potassium of 3.2 mEq/L and a bicarbonate level of 19 mEq/L during a hospitalization for a D and C. She was treated with oral potassium and bicarbonate supplements and then weaned these off after 4 months of therapy. Six weeks later, she developed myalgias and collapsed due to profound weakness. She was found to have a serum bicarbonate level of 14 mEq/L with a serum potassium of 1.9 mEq/L. 140 114 13 Calcium 9.1 1.9 14 1 Phosphorus 3.5 ABG-pH 7.29, PCO2 30, pO2 100 Urine K 46 Urine Na 36 Urine Cl 42 Urine Osm 580 UA ph 6.8 trace protein No casts 10-15 white cells per high power field Which of the following is the correct diagnosis? • Type IV RTA • Diarrhea • Type I RTA • Renal tubular alkalosis • Proximal RTA

  29. Practical Approach (Hyperchloremic metabolic acidosis) Urinary Anion Gap NegativePositive Type 2 RTA Diarrhea DKA/Toluene HCl (Hyperalimentation) Urine pH and Plasma K Urine pH < 5.5, K Urine pH > 5.5, K nl/lowUrine pH > 5.5, K  Type 4 Type 1 (secretory defect Type 1 (voltage) or back-leak)

  30. Type I Classic Distal RTA-Mechanism 1 Tubular lumen Na+ Peritubular Capillary Na+ 3Na+ ATPase (-) 2K+ (-) H+ Retention K+ R-Aldo K+ Wasting Urine pH > 5.5 Ca-P stones Cl- ATPase 3Na+ H+ ATPase H2O 2K+ (-) T HCO3- OH- + CO2 K+ Cl- ATPase (-) H+

  31. Type I Classic Distal RTA-Mechanism 2 Tubular lumen Na+ Peritubular Capillary Na+ 3Na+ ATPase (-) 2K+ (-) H+ Retention K+ R-Aldo K+ Wasting Urine pH > 5.5 Ca-P stones Cl- ATPase 3Na+ H+ ATPase H2O 2K+ (-) T HCO3- OH- + CO2 K+ Cl- ATPase (-) H+

  32. Type I Distal RTA-Mechanism 3 Tubular lumen Na+ Peritubular Capillary Na+ 3Na+ ATPase (-) 2K+ (-) K+ R-Aldo K+ Wasting Urine pH > 5.5 Ca-P stones Cl- Backleak of H+ ATPase 3Na+ H+ H+ ATPase H2O H+ Retention 2K+ (-) T HCO3- OH- + CO2 K+ Cl- ATPase (-) H+

  33. Question 13 A 32 y.o. male presents with paresthesias, perioral numbness, and generalized weakness. He is not on any medications. The BP is 120/88, and the physical exam is remarkable for dental caries. Earlier in the day he had attended a birthday party for his nephew. Labs show Na 139, potassium 2.8, chloride 90, bicarbonate 38. Urine sodium 28, urine potassium 38, urine chloride < 10, urine pH 6.2, urine calcium:creatinine ratio 0.2 (mmol/mmol). Is this: • Barrter syndrome • Vomiting • Gitelman syndrome • Hypokalemia periodic paralysis • Licorice ingestion

  34. Urine Na+ and Cl- in the Differential Diagnosis of Metabolic Alkalosis and Hypokalemia Urine Electrolytes Na+ Cl- Condition (meq/L) Vomiting Alkaline urine >15 <15 Acidic urine <15 <15 Diuretic Drug active >15 >15 Remote use <15 <15 Hyperaldosteronism >15 >15

  35. Question 14 You are asked to evaluate a 42 year old woman because of hyponatremia. She has a history of schizophrenia and is currently hospitalized because of suicidal and homicidal ideation. Her admission laboratory studies obtained during a psychiatric hospitalization were normal. Current medications are haloperidol and benztropine mesylate. Physical exam shows pulse 92 supine, 100 standing, BP 112/82 supine and 108/88 standing. Occasional involuntary movements of the tongue and lips are noted. There is no edema. Labs show sodium 120 mEq/L, potassium 4.2 mEq/L, chloride 85 mEq/L, bicarb 27 mEq/L, BUN 8 mg/dL, creatinine 0.8 mg/dL, serum osmolality 250 mOsm/kg, TSH 3.8 microunits/mL, uric acid 3.2 mg/dL; Urine sodium 12, urine potassium 3, urine chloride 10, urine osmolality 55. Which of the following is the most likely cause of this patient’s hyponatremia? • Primary polydipsia • Mineralocorticoid deficiency • Reset osmostat • Diuretic abuse • SIADH

  36. Question 15 A 49 y.o. female is admitted to the hospital because of severe right sided abdominal pain requiring administration of narcotic analgesics. The patient is unable to provide a complete medical history, but reports that she has had seizures for as long as she can remember. Physical exam reveals papular skin lesions in the malar area. Bilateral flank masses are noted. There is a 2-cm periungual nodular lesion on the right great toe. Hematocrit is 25%. Serum creatinine is 5.5 mg/dL. CT of the abdomen without contrast reveals enlarged kidneys with bilateral renal cysts of varying size in the cortex and the medulla; several variably sized masses with densities identical to perinephric fat are also detected in areas not involved with cysts. Which if the following is the most likely diagnosis? • ADPCKD • Von Hippel-Lindau disease • Medullary cystic kidney disease • Tuberous sclerosis • Bilateral renal dysplasia

  37. Question 16 A 66-year-old man comes for a follow-up examination for elevated blood pressure. He has a history of chronic kidney disease and hypertension well controlled with hydrochlorothiazide. One week ago, he was evaluated in the office after obtaining several home blood pressure measurements averaging 145/90 mm Hg. Enalapril was added at that time. He has felt well and has no history of cough, lower-extremity edema, or dyspnea. He also takes low-dose aspirin. On physical examination today, temperature is normal, blood pressure is 126/70 mm Hg, respiration rate is 18/min, and pulse rate is 78/min and regular. On cardiac examination, the point of maximal impulse is laterally displaced and an S4 gallop is heard. There is no edema. • In addition to dietary potassium restriction, which of the following is the most appropriate next step in this patient’s management? • Add diltiazem • Discontinue enalapril; switch to metoprolol • Repeat creatinine and potassium measurement in 1 week • Kidney arteriography

  38. Question 17 A 55 y.o. male with stage 3 chronic kidney disease presents for routine follow up. Laboratory studies show calcium 9.2 mg/dL, phosphorus 2.8 mg/dL, PTH 215 pg/mL, 25-OH vitamin D 10 ng/mL, 1,25-(OH)2-vitamin D 19. Which one of the following would you recommend? • Restrict dietary phosphorus to 600 mg daily • Start sevelamer 800 mg three time daily with meals • Start calcitriol 0.25 mcg once daily • Start ergocalciferol 50,000 units once weekly

  39. Time Course of Physiologic Alteration in Calcium, Phosphorus, Vitamin D and PTH in CKD Stage 1 Stage 2 Stage 3 Stage 4 Stage 5  25-OH-vitamin D  1,25-(OH)2-vitamin D Transient Post-prandial Hypocalcemia Hypocalcemia Hyperphosphatemia Increased PTH secretion 90 80 70 60 50 40 30 20 <15 GFR (mL/min/1.73 m2)

  40. Question 18 A 59 y.o. female presents with 2 weeks of R hip pain. The past history is significant for end stage renal disease due to stone disease complicating type I distal renal tubular acidosis now on peritoneal dialysis, s/p bilateral nephrectomy, s/p living donor kidney transplant 5 years ago with loss of allograft function after 3 years from chronic rejection, gout, and hypothyroidism. Medications include levothyroxine 0.15 mg p.o. daily, allopurinol 150 mg p.o. daily, aspirin 81 mg p.o. daily, erythropoietin 10,000 units subcutaneously weekly, colchicine 0.6 mg p.o. daily, sevelamer 800 mg three times daily with meals, multivitamin one daily, and calcitriol 0.25 mcg once daily. There is no history of exposure to aluminum containing medications.

  41. Question 18 On physical exam there is tenderness over the lateral trochanteric bursa and pain with internal and external rotation of the hip. Labs show calcium 9.1 mg/dL, phosphorus 5.6 mg/dL, intact PTH 21 pg/mL, 1,25-dihydroxy-vitamin D 52 pg/mL (reference range 15-75); 25-hydroxy-vitamin D 25 ng/mL (reference range 15-57), alkaline phosphatase 86 U/L (reference range 38-126). TSH is normal at 2.5 microIU/mL (reference range 0.6-3.3). Plain films of the right hip show diffuse osteopenia and an area of lucency along the medial aspect of the femoral neck on the right consistent with stress fracture.

  42. Question 18 Which of the following is the most likely diagnosis? A. Adynamic bone disease B. Beta-2 microglobulin associated amyloidosis C. Osteomalacia D. Osteitis fibrosa cystica

  43. Question 19 A 64-year-old woman is referred for evaluation of a rising serum creatinine level. She had been recently diagnosed with severe reflux esophagitis for which she was treated with omeprazole. Over the past several weeks she had noted onset of generalized malaise, fatigue, and anorexia. Screening laboratory studies revealed that the serum creatinine level had risen to 2.5 mg/dL (0.221 mmol/L) compared with a previous value of 1.2 mg/dL (0.106 mmol/L) 6 weeks ago.

  44. Question 19 On physical exam the blood pressure was 120/60 mm Hg. There was no rash or edema. Laboratory studies showed sodium 138 mmol/L, potassium 4.7 mmol/L, chloride 103 mmol/L, total carbon dioxide 17 mmol/L, BUN 43 mg/dL (15.3 mmol/L), creatinine 2.5 mg/dL (0.221 mmol/L), hemoglobin 11 gm/dL (110 gm/L), white count 8,200 mm3 without eosinophilia. Serologic studies including ANA and ENA all returned negative. Urinalysis revealed trace protein and 35 white blood cells per high-power field without casts.

  45. Question 19 What is the most likely diagnosis? • Ischemic acute tubular necrosis • Acute interstitial nephritis • Myeloma cast nephropathy • Pyelonephritis • Obstruction due to kidney stones

  46. Etiology of Acute Interstitial Nephritis (AIN) Etiology Frequency Drugs 71% Penicillins and cephalosporins NSAIDs, including COX-2 inhibitors Rifampin Sulfonamides Quinolones Allopurinol Proton pump inhibitors Indinavir 5-aminosalicylates (e.g. mesalamine) H-2 blockers Infection 15% Tubulointerstitial 5% nephritis and uveitis Sarcoidosis 1% González E, et al. Kidney Int 2008; 73: 940–946. Baker RJ and Pusey CD. Nephrol Dial Transplant 2004;19:8-11.

  47. Clinical Features of AIN González E, et al. Kidney Int 2008; 73: 940–946.

  48. Corticosteroid Treatment for AIN P<0.05 No steroids Steroid-treated • Chronic dialysis in 44% with no steroids vs 3.8% • with steroids (Small study-52 patients treated with • steroids, 9 managed with drug withdrawal alone) • Trend toward more fibrosis on biopsy when steroids • withheld and when started later (NS) González E, et al. Kidney Int 2008; 73: 940–946.

  49. Proton Pump Inhibitors (PPI) and AIN • 95 million prescriptions written for PPI in the United States in 2005 • PPI’s are the most common cause of drug induced interstitial nephritis (32%) in an adverse drug reaction registry in New Zealand (Simpson et al. Nephrology 2006;11:381-385).

More Related